2Gao Y,Chen G,Tian H,et al.Prevalence of hypertension in China: a cross-sectional study[J].PLoS 〇ne,2013,8(6):e65938.
3Martell-Claros N, Galgo-Nafria A.OPENJOVEN study group. Cardiovascular risk profile of young hypertensive patients: the OPENJOVEN Study[J].Eur J Prev Cardiol,2012 ,19(3):534-540.
4SPRINT research group, Wright JT Jr, Williamson JD, et al.A randomized trial of intensive versus standard blood-pressure con- trol[J].N Engl J Med,2015,373(22):2103-2116.
5Lawes CM,Rodgers A, Bennett DA, et al.Blood pressure and cardiovascular disease in the Asia Pacific region[J].J Hypertens,2003,21(4):707-716.
6Materson BJ, Reda DJ, Cushman WC, et al.Single-drug therapy for hypertension in men.A comparison of six antihypertensive agents with placebo.The department of veterans affairs coopera- tive study group on antihypertensive agents[J], N Engl J Med,1993,328(13):914-921.
7Dickerson JE, Hingorani AD, Ashby MJ, et al.Optimisation of antihypertensive treatment by crossover rotation of four major classes[J].Lancet,1999,353(9169):2008-2013.
8Deary AJ, Schumann AL,Murfet H,et al.Double-blind, place- bo-controlled crossover comparison of five classes of antihyperten- sive drugs[J].J Hypertens,2002,20(4):771-777.
9Williams B,Poulter NR, Brown MJ, et al.Guidelines for man- agement of hypertension: report of the fourth working party of the British Hypertension Society,2004-BHS W[J].J Hum Hypertens,2004,18(3):139-185.
10National Clinical Guideline Centre (UK).Hypertension; the clin- ical management of primary hypertension in adults; update of clin- ical guidelines 18 and 34[M].London: Royal College of Physi- cians (UK);2011.
